IMVAX
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies for the treatment of malignant gliomas and other cancers with unmet medical needs. Its product, IGV-001, is an autologous tumor cell vaccine that delivers a multi-pronged response against tumor cells by leveraging the patient’s immune system as a defense mechanism. The company was incorporated in 2015 by David W. Andrews, Craig Hooper, Arthur W. Howe, and Peter B. Corr in Philadelphia, Pennsylvania.
IMVAX
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2015-01-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.imvax.com
Total Employee:
11+
Status:
Active
Contact:
215-485-0071
Email Addresses:
[email protected]
Total Funding:
166.69 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Actinobac Biomed
Actinobac Biomed focuses on the development of pharmaceutical technologies derived from agents that target LFA-1.
Alvine Pharmaceuticals
Alvine Pharmaceuticals is a biotechnology company developing therapeutics for autoimmune and inflammatory diseases.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Bio-Detection K9
Bio-Detection K9 is a biotech company specialized in the canine detection of bacteria and viruses particular of covid-19.
Biofourmis
Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics.
Clear Vascular
Clear Vascular offers Tin-Annexin, an injectable radiopharmaceutical agent for imaging and therapy of inflammatory tissues.
Clinials
Clinials is a participant recruitment platform Using AI to Help Researchers Communicate Medical Information to Patients
Edgemont Pharmaceuticals
Edgemont Pharmaceuticals focuses on the field of neuroscience and develops novel drug formulations and therapies to improve patient care.
Hawkeye Bio
Hawkeye Bio is a medical technology company focused on the early detection of cancer, infectious disease and autoimmune disease.
Immunowake
Immunowake is a biotechnology company that focuses on identifying new therapies for patients who do not respond to existing immunotherapies.
ImpactRx
ImpactRx operates as a promotion research organization for the pharmaceutical industry in the United States.
Inmagene Biopharmaceuticals
It is a leading biotech company focused on immunology-related therapeutic areas.
InSite Vision
InSite Vision develops therapeutic products for common eye problems: infection, pain and inflammation in ocular surgery and glaucoma.
LipUm
LipUm operates as a biotechnology company that offers anti-inflammatory drugs.
Oragenics
Oragenics develops oral probiotic products and antibiotics for humans and companion pets.
Peptinnovate
Peptinnovate Limited, is a U.K. drug development company developing a ‘first in class’ immune regulating therapy for inflammatory diseases.
PNP Therapeutics
PNP Therapeutics is engaged in the development of technology and proprietary products for the treatment of cancer.
PPD
PPD is a global contract research organization that offers drug development, laboratory, and lifecycle management services.
SolAeroMed
SolAeroMed is a developer of a novel therapeutic used to treat obstructive lung diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
HP WILD HOLDING AG
HP WILD HOLDING AG investment in Series C - Imvax
Magnetar Capital
Magnetar Capital investment in Series C - Imvax
Invus
Invus investment in Series C - Imvax
Ziff Capital Partners
Ziff Capital Partners investment in Series C - Imvax
TLP Investment Partners
TLP Investment Partners investment in Series C - Imvax
WILD Group Management
WILD Group Management investment in Series B - Imvax
Magnetar Capital
Magnetar Capital investment in Series B - Imvax
Ziff Capital Partners
Ziff Capital Partners investment in Series B - Imvax
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-16 | Imvax Appoints John M. Limongelli as Chief Legal Officer |
Official Site Inspections
http://www.imvax.com Semrush global rank: 5.52 M Semrush visits lastest month: 1.54 K
- Host name: 141.222.135.34.bc.googleusercontent.com
- IP address: 34.135.222.141
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
